Proteomics screening post pediatric allogeneic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and CMV reactivation
Preprint
Abstract
Objective: To study kinetics and associations between inflammation related proteins in circulation after pediatric allogenic hematopoietic stem cell transplantation (HSCT) to reveal proteomic signatures or individual soluble proteins associated with specific complications post HSCT. Methods: We used a proteomics method called Proximity Extension Assay to repeatedly measure 180 different proteins together with clinical variables, cellular immune reconstitution, and blood viral copy numbers in 27 children aged 1-18 years during a two-year follow up after allogenic HSCT. Protein profile analysis was done using unsupervised hierarchical clustering and a regression-based method, while Bonferroni-corrected Mann-Whitney U test was used for time point specific comparison of individual proteins against outcome. Results: At 6 months after allogenic HSCT, we could identify a protein profile pattern associated with occurrence of the complications chronic graft-versus-host disease, viral infections, relapse, and death. When protein markers were analyzed separately, the plasma concentration of the inhibitory and cytotoxic T cell surface protein FCRL6 (Fc receptor-like 6) was higher in patients with CMV viremia (log2-fold change 1.5 (p0.00099), 2.5 (p=0.00035) and 2.2 (p=0.045) at time points 6, 12 and 24 months). Flow cytometry confirmed that FCRL6 expression was higher in innate-like γδ T cells, indicating that these cells have a role in controlling CMV reactivation in HSCT recipients. Conclusions: The potentially druggable FCRL6 receptor on cytotoxic T cells appears to have a role in controlling CMV viremia post-HSCT. Our results suggest that system level analysis is a useful addition to the studying of single biomarkers in allogeneic HSCT.Keywords
This publication has 34 references indexed in Scilit:
- Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent ScalabilityPLOS ONE, 2014
- Incidence, risk factors, and outcome of bloodstream infections during the pre‐engraftment phase in 521 allogeneic hematopoietic stem cell transplantationsTransplant Infectious Disease, 2013
- Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell TransplantationJournal of Clinical Oncology, 2011
- FCRL6 receptor: Expression and associated proteinsImmunology Letters, 2011
- Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experienceTransplant Infectious Disease, 2010
- FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B‐cell chronic lymphocytic leukemiaEuropean Journal of Immunology, 2008
- Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanismThe FASEB Journal, 2006
- maSigPro: a method to identify significantly differential expression profiles in time-course microarray experimentsBioinformatics, 2006
- Matrix Metalloproteinases: Role In ArthritisFrontiers in Bioscience-Landmark, 2006
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974